Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Channel Therapeutics Stock Price, Quotes and Forecasts | AMEX:CHRO | Benzinga

Q: What sector and industry does Channel Therapeutics (CHRO) operate in?

Channel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

Explore Channel Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CHRO.

Open	$1.29
Close	$1.19
Volume / Avg.	32.35K / 672.42K
Day Range	$1.18 - $1.29
52 Wk Range	0.45 - 3.80
Market Cap	$7.17M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	42
Short Interest	0.19%
Days to Cover	2.52

Recent News

Gold Falls Over 1%; D.R. Horton Posts Downbeat Earnings

Avi Kapoor

Dow Falls Over 1%; US Initial Jobless Claims Decline

Avi Kapoor

EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity

Ligand and Channel Therapeutics to merge in $50 million deal to launch Zelsuvmi for molluscum and advance NaV 1.7 chronic pain programs.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$1.29
Close	$1.19
Volume / Avg.	32.35K / 672.42K
Day Range	$1.18 - $1.29
52 Wk Range	0.45 - 3.80
Market Cap	$7.17M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	42
Short Interest	0.19%
Days to Cover	2.52

About Channel Therapeutics Corporation

Sector

Health Care

Industry

Biotechnology

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing n...

Got Questions? Ask

Analyze CHRO's financials

What is CHRO's 200-day MA?

What is CHRO's current price trend?

What is CHRO's P/E ratio?

What is the Pivot support level for CHRO?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Channel Therapeutics (CHRO) stock?

You can purchase shares of Channel Therapeutics (AMEX:CHRO) through any online brokerage.

View our list of the best stock brokerages

Who are Channel Therapeutics (CHRO) competitors?

Other companies in Channel Therapeutics’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Intensity Therapeutics (NASDAQ:INTS), Palatin Techs (AMEX:PTN), Indaptus Therapeutics (NASDAQ:INDP) and GT Biopharma (NASDAQ:GTBP).

What is the forecast, or price target, for Channel Therapeutics (CHRO) stock?

There is no analysis for Channel Therapeutics to provide a consensus price target.

What is the current price for Channel Therapeutics (CHRO)?

The stock price for Channel Therapeutics (AMEX: CHRO) is $1.19 last updated May 5, 2025 at 8:00 PM EDT.

Does Channel Therapeutics (CHRO) pay a dividend?

There are no upcoming dividends for Channel Therapeutics.

When is Channel Therapeutics (AMEX:CHRO) reporting earnings?

Channel Therapeutics’s Q1 earnings are confirmed for Monday, May 19, 2025.

Is Channel Therapeutics (CHRO) going to split?

There is no upcoming split for Channel Therapeutics.

What sector and industry does Channel Therapeutics (CHRO) operate in?

Channel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

Comments

Channel Therapeutics Stock Price, Quotes and Forecasts

Channel Therapeutics (CHRO) Forecast